|
Delayed
NSE India S.E.
01:05:25 2026-10-05 am EDT
|
5-day change | 1st Jan Change | ||
| 94.65 INR | +3.05% |
|
+10.38% | -14.03% |
Sales 2026 by Business Segment
Sales 2026 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
Pharmaceutical Products | |||||||
Drugs And Chemicals | 595M | 616M | 826M | 1.04B | 1.12B | ||
Total Assets | 350M | 466M | 593M | 1.22B | 1.12B | ||
Interest Expense | -2.65M | -5.2M | -7.27M | -8.43M | -17.63M | ||
Income Tax Expense | 16.19M | 19.31M | 43.52M | 51.18M | 30.89M | ||
CAPEX | -19.31M | -30.67M | -9.4M | -34.71M | -53.34M | ||
EBT | 57.85M | 69.6M | 144M | 187M | 180M | ||
D&A | 4.6M | 5.5M | 5.68M | 6.36M | 8.24M | ||
Net Income | 41.66M | 50.28M | 101M | 136M | 149M |
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
India | 595M | 616M | 826M | 1.04B | 1.12B | ||
Total Assets | 350M | 466M | 593M | 1.22B | 1.12B | ||
Interest Expense | -2.65M | -5.2M | -7.27M | -8.43M | -17.63M | ||
Income Tax Expense | 16.19M | 19.31M | 43.52M | 51.18M | 30.89M | ||
D&A | 4.6M | 5.5M | 5.68M | 6.36M | 8.24M | ||
CAPEX | -19.31M | -30.67M | -9.4M | -34.71M | -53.34M | ||
Net Income | 41.66M | 50.28M | 101M | 136M | 149M | ||
EBT | 57.85M | 69.6M | 144M | 187M | 180M |
- Stock Market
- Stocks
- QUESTLAB Stock
- Financials Quest Laboratories Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
